Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

Vitiligo is believed to be an autoimmune condition where the body attacks its own healthy melanin-producing skin cells by mistake. It may be hereditary or triggered by a particular event like ...

Skin pigmentation disorders affect people across the world. One of them, vitiligo, is said to have a worldwide incidence of 1 ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

Some treatments may not be suitable for infants. If a caregiver decides to treat an infant’s vitiligo, a doctor will create a treatment plan based on the child’s age, health, and other factors.

VASI is a valid and reliable tool that is responsive to change and has defined thresholds for meaningful improvement for patients with vitiligo.